MNOV FY 2023 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena

MNOVMediciNova, Inc.

$69M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$1M100.0% margin

Operating Income

-$10M-990.0% margin

Net Income

-$9M-857.2% margin

EPS (Diluted)

$-0.17

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$710,710

Balance Sheet

Total Assets

$66M

Total Liabilities

$4M

Stockholders' Equity

$62M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$10M	-$15M	+32.3%
Net Income	-$9M	-$14M	+39.1%